Middle Cerebral Artery Infarction
6
0
1
3
Key Insights
Highlights
Success Rate
75% trial completion
Treatment Research
12 treatments under study, led by Lokomat Physical Therapy
Research Leaders
12 sponsors active, led by All India Institute of Medical Sciences
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
16.7%
1 terminated out of 6 trials
75.0%
-11.6% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (6)
Roods vs PNF for Upper Limb Function in Acute MCA Stroke
Stereotactic Infarct Tissue Aspiration for Malignant Infarction of Middle Cerebral Artery
Stem Cell Therapy For Acute Ischemic Stroke Patients
Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct
Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients
Gait Training for Persons With Stroke
Research Network
Common Treatments
- Lokomat Physical Therapy1
- Roods Facilitatory Techniques1
- Intercerebral Implantation Of Autulogous Stem Cells1
- Medical Therapy1
- Autologous Bone Marrowderived Mesenchymal Stem Cells1
Active Sponsors
- All India Institute of Medical Sciences1
- National University of Malaysia1
- Post Graduate Institute of Medical Education and Research, Chandigarh1
- Ministry of Science and Technology, India1
- Cytopeutics Sdn. Bhd.1
Top Investigators
Director
All India Institute of Medical Sciences
UKM Medical Centre
China Medical University Hospital
Hammel Neurorehabilitation and Research Center, Denmark
Related Conditions
- Stroke3
- Anterior Cerebral Artery Infarction1